Clinical Trial Update: Pilot Clinical Trial to Evaluate the UNI-DEB for Unresectable Hepatocellular Carcinoma [NA]

View source ↗

Summary

A pilot clinical trial evaluating UNI-DEB for unresectable hepatocellular carcinoma conducted by Jeil Pharmaceutical Co., Ltd. has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• UNI-DEB

Snippet

Sponsor: Jeil Pharmaceutical Co., Ltd. | Conditions: Hepatocellular Carcinoma Non-resectable | NA | Status: COMPLETED